Affiliation:
1. Altai State Medical University; Altai Regional Cardiological Clinic
2. Altai State Medical University
Abstract
Amyloidosis is a systemic disease caused by accumulation of insoluble amyloid proteins in the tissues. Cardiac amyloidosis (CA) lead to a severe heart failure, which is often therapy resistant. The severity of heart failure does not correspond to the degree of decrease in systolic function of the left ventricle, since diastolic function is more impairing. Early diagnosis of cardiac amyloidosis is important due to the presence of treatment regimens for this disease nowadays. The “gold standard” for cardiac amyloidosis diagnosis is myocardial biopsy, but non-invasive diagnostic methods are also of great importance. The aim of the article is a review of the ultrasound signs of cardiac amyloidosis, including the use of modern technologies, which helps to suspect CA to provide a further examination.
Reference43 articles.
1. Donnelly J.P., Hanna M. Cardiac amyloidosis: An update on diagnosis and treatment. Cleve Clin. J. Med. 2017; 84 (12, Suppl. 3):12–26. http://doi.org/10.3949/ccjm.84.s3.02
2. Siddiqi O.K., Ruberg F.L. Cardiac amyloidosis: An update on pathophysiology, diagnosis, and treatment. Trends Cardiovasc. Med. 2018; 28 (1): 10–21. http://doi.org/10.1016/j.tcm.2017.07.004
3. Reznik E.V., Nguyen T.L., Stepanova E.A., Ustyuzhanin D.V., Nikitin I.G. Cardiac Amyloidosis: Internist and Cardiologist Insight. The Russian Archives of Internal Medicine. 2020; 10 (6): 430–457. https://doi.org/10.20514/2226- 6704-2020-10-6-430-457
4. Tereshchenko S.N., Zhirov I.V., Moiseeva O.M., Adasheva T.V., Ansheles A.A., Barbarash O.L., Galyavich A.S., Gudkova A.I., Zateyshchikov D.A., Kostareva A.A., Nasonova S.N., Nedogoda S.V., Pecherina T.B., Ryzhkova D.V., Sergienko V.B. Practical guidelines for the diagnosis and treatment of transthyretin amyloid cardiomyopathy (ATTR-CM or transthyretin cardiac amyloidosis).
5. Pinney J.H., Smith C.J., Taube J.B., Lachmann H.J., Venner C.P., Gibbs S.D., Dungu J., Banypersad S.M., Wechalekar A.D., Whelan C.J., Hawkins P.N., Gillmore J.D. Systemic amyloidosis in England: an epidemiological study. Br. J. Haematol. 2013; 161 (4): 525–532. http://doi.org/10.1111/bjh.12286